Most Recent
Seeing red: Priceline can’t trade mark signature pink
Discount pharmacy Priceline cannot trade mark the signature bright pink that adorns it shopfront signs and awnings, an IP Australia delegate has found.
More clinics to be pulled into Monash IVF class action over embryo destruction
Six more fertility clinics in states across the country are set to be pulled into a class action against Monash IVF on behalf of hundreds of men and women demanding damages for the alleged destruction of potentially viable embryos.
Philips defends class action, says sleep devices weren’t defective when sold
Philips Electronics has hit back at a class action over recalled sleep apnea machines that contained a foam component that could allegedly degrade and cause consumers to inhale dangerous chemicals, saying the devices were not defective when they were sold.
Deep sleep therapy case re-awakened as Full Court grants appeal
Two psychiatrists who administered the controversial deep sleep therapy at the Chelmsford Private Hospital in the 1970s have won a Full Federal Court appeal in their defamation cases against publisher HarperCollins, with one of the cases being sent back for a re-trial.
Pelvic mesh class actions nearing settlement, court told
Settlement talks in three class actions on behalf of women injured by allegedly defective pelvic mesh products have progressed “substantially”, a court has heard.
Plastic surgeon wins $450,000 in defamation case over fake review by rival
A Gold Coast cosmetic surgeon has won his defamation case against a competitor who posted a phony online review, with a judge ordering damages of more than $450,000.
Smile Direct Club bites back in lawsuit over teeth straightener claims
The maker of the popular Invisalign dental aligners may soon face a cross-claim from competitor SmileDirectClub, which it sued for allegedly misleading consumers about the cost and efficacy of its direct-to-consumer teeth alignment kits. 
Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.
J&J won’t contest follow-on pelvic mesh class action
An additional 1,200 women who were implanted with defective pelvic mesh devices will be eligible for compensation after Johnson & Johnson unit Ethicon agreed that findings in an earlier class action which it unsuccessfully fought all the way to the High Court should apply to a follow-on class action.
Judge says vaccine lawsuit against Monash Health was not ‘doomed to fail’
A judge has declined to award costs against a group of nurses who recently dropped their Fair Work lawsuit against Monash Health, saying the case was not "doomed to fail" and noting the “extremity” of the Victorian government’s vaccine mandate for workers.